Literature DB >> 5308739

The effect of L-dopa on monoamine metabolites in Parkinson's disease.

M H van Woert, M B Bowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5308739     DOI： 10.1007/BF01895555

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  9 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

2.  Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Authors:  G Campanella; S Algeri; C Cerletti; E Dolfini; A Jori; F Rinaldi
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Authors:  C Casati; A Agnoli; A Jori; E Dolfini
Journal:  Z Neurol       Date:  1973-04-02

4.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

6.  Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.

Authors:  M B Bowers; D Moore; D Tarsy
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

7.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

8.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

9.  Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.

Authors:  R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.